Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 163

    1.

    Autoimmune diabetes and the circle of tolerance.

    Rossini AA.

    Diabetes. 2004 Feb;53(2):267-75.PMID: 14747275 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Prevention of type 1 diabetes.

    Rabinovitch A, Skyler JS.

    Med Clin North Am. 1998 Jul;82(4):739-55. Review.PMID: 9706119 [PubMed - indexed for MEDLINE]Related articles

    3.

    Tolerogenic strategies to halt or prevent type 1 diabetes.

    Cooke A, Phillips JM, Parish NM.

    Nat Immunol. 2001 Sep;2(9):810-5.PMID: 11526391 [PubMed - indexed for MEDLINE]Related articles

    4.

    Negative T cell costimulation and islet tolerance.

    Gao W, Demirci G, Li XC.

    Diabetes Metab Res Rev. 2003 May-Jun;19(3):179-85. Review.PMID: 12789650 [PubMed - indexed for MEDLINE]Related articles

    5.

    Coinhibitory T-cell signaling in islet allograft rejection and tolerance.

    Truong W, Hancock WW, Anderson CC, Merani S, Shapiro AM.

    Cell Transplant. 2006;15(2):105-19. Review.PMID: 16719045 [PubMed - indexed for MEDLINE]Related articles

    6.

    Beneficial autoimmunity in Type 1 diabetes mellitus.

    Hauben E, Roncarolo MG, Nevo U, Schwartz M.

    Trends Immunol. 2005 May;26(5):248-53.PMID: 15866237 [PubMed - indexed for MEDLINE]Related articles

    7.

    Does autoantigen administration inhibit recurrence of type 1 diabetes in transplanted islets?

    Mojtahedi Z, Farjadian S, Ghaderi A.

    Med Hypotheses. 2005;64(5):986-8.PMID: 15780496 [PubMed - indexed for MEDLINE]Related articles

    8.

    Advances in type I diabetes associated tolerance mechanisms.

    Chentoufi AA, Binder NR, Berka N, Abunadi T, Polychronakos C.

    Scand J Immunol. 2008 Jul;68(1):1-11. Epub 2008 May 9. Review.PMID: 18482207 [PubMed - indexed for MEDLINE]Related articles

    9.

    Development of new strategies to prevent type 1 diabetes: the role of animal models.

    Hänninen A, Hamilton-Williams E, Kurts C.

    Ann Med. 2003;35(8):546-63. Review.PMID: 14708966 [PubMed - indexed for MEDLINE]Related articles

    10.

    The role of T-cells in the pathogenesis of Type 1 diabetes: from cause to cure.

    Roep BO.

    Diabetologia. 2003 Mar;46(3):305-21. Epub 2003 Mar 22. Review.PMID: 12687328 [PubMed - indexed for MEDLINE]Related articles

    11.

    Multimerized T cell epitopes protect from experimental autoimmune diabetes by inducing dominant tolerance.

    Piaggio E, Mars LT, Cassan C, Cabarrocas J, Hofstätter M, Desbois S, Bergereau E, Rötzschke O, Falk K, Liblau RS.

    Proc Natl Acad Sci U S A. 2007 May 29;104(22):9393-8. Epub 2007 May 16.PMID: 17517665 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    T-cell assays to determine disease activity and clinical efficacy of immune therapy in type 1 diabetes.

    van de Linde P, Roep BO.

    Am J Ther. 2005 Nov-Dec;12(6):573-9. Review.PMID: 16280651 [PubMed - indexed for MEDLINE]Related articles

    13.

    Islet cell autoimmunity and transplantation tolerance: two distinct mechanisms?

    Pearson T, Markees TG, Serreze DV, Pierce MA, Wicker LS, Peterson LB, Shultz LD, Mordes JP, Rossini AA, Greiner DL.

    Ann N Y Acad Sci. 2003 Nov;1005:148-56.PMID: 14679049 [PubMed - indexed for MEDLINE]Related articles

    14.

    Islet transplantation in patients with autoimmune diabetes induces homeostatic cytokines that expand autoreactive memory T cells.

    Monti P, Scirpoli M, Maffi P, Ghidoli N, De Taddeo F, Bertuzzi F, Piemonti L, Falcone M, Secchi A, Bonifacio E.

    J Clin Invest. 2008 May;118(5):1806-14.PMID: 18431516 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    IL-10 diminishes CTLA-4 expression on islet-resident T cells and sustains their activation rather than tolerance.

    Gregg RK, Bell JJ, Lee HH, Jain R, Schoenleber SJ, Divekar R, Zaghouani H.

    J Immunol. 2005 Jan 15;174(2):662-70.PMID: 15634884 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    New therapies aimed at the preservation or restoration of beta cell function in type 1 diabetes.

    Keymeulen B.

    Acta Clin Belg. 2006 Sep-Oct;61(5):275-85. Review.PMID: 17240745 [PubMed - indexed for MEDLINE]Related articles

    17.

    Hematopoietic stem cell therapy for type 1 diabetes: induction of tolerance and islet cell neogenesis.

    Burt RK, Oyama Y, Traynor A, Kenyon NS.

    Autoimmun Rev. 2002 May;1(3):133-8. Review.PMID: 12849006 [PubMed - indexed for MEDLINE]Related articles

    18.

    Toward cell-based therapy of type I diabetes.

    Kabelitz D, Geissler EK, Soria B, Schroeder IS, Fändrich F, Chatenoud L.

    Trends Immunol. 2008 Feb;29(2):68-74. Epub 2008 Jan 7.PMID: 18182324 [PubMed - indexed for MEDLINE]Related articles

    19.

    Strategies for inducing immunological tolerance of xenogeneic islet transplants in type I diabetes.

    Thivolet C.

    Diabetes Metab. 1998 Jun;24(3):225-8. Review.PMID: 9690054 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Induction of robust diabetes resistance and prevention of recurrent type 1 diabetes following islet transplantation by gene therapy.

    Tian C, Ansari MJ, Paez-Cortez J, Bagley J, Godwin J, Donnarumma M, Sayegh MH, Iacomini J.

    J Immunol. 2007 Nov 15;179(10):6762-9.PMID: 17982066 [PubMed - indexed for MEDLINE]Related articlesFree article